USPTO Examiner GOLLAMUDI NEERAJA - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18815986Safety Infusion Port Needle ApparatusAugust 2024November 2024Allow300YesNo
18509732Feedback Mechanism for an Injection DeviceNovember 2023December 2024Allow1300NoNo
18381758CATHETER DESIGNS FOR ENHANCED COLUMN STRENGTHOctober 2023October 2024Allow1210NoNo
18212767Injection DeviceJune 2023April 2025Allow2240YesNo
18312674EXTENSION TUBE ASSEMBLY AND RELATED MEDICAL FLUID TRANSFER SYSTEMS AND METHODSMay 2023February 2025Allow2221NoNo
17979006GUIDE WIRENovember 2022March 2023Allow500YesNo
18048487MEDICAL FLUID TRANSFER AND INJECTION APPARATUS AND METHODOctober 2022June 2025Abandon3220NoNo
17888676LOW-DRAG SEPTUM FOR A CATHETER SYSTEMAugust 2022January 2024Allow1720YesNo
17877646Safe Cannulation Devices, Methods, and SystemsJuly 2022August 2023Allow1320NoNo
17855910PRE-FILLED CARTRIDGE-BASED DRUG DELIVERY DEVICEJuly 2022May 2024Abandon2220NoNo
17734475ENTERAL FLUID DELIVERY SYSTEMMay 2022October 2023Allow1820YesNo
17725201ADMINISTRATION ASSEMBLY FOR A MEDICAMENT DELIVERY DEVICE AND A MEDICAMENT DELIVERY DEVICE COMPRISING THE SAMEApril 2022February 2025Allow3430NoNo
17713180CATHETER ASSEMBLYApril 2022October 2023Allow1820YesNo
17623051Plastic Flange for a Medical Container, Medical Container Including This Plastic Flange, and a Method for Manufacturing This Medical ContainerDecember 2021August 2023Allow2010NoNo
17644390Medicament Delivery DeviceDecember 2021August 2024Allow3250YesNo
17614046PUNCTURE NEEDLE, PUNCTURE NEEDLE KIT, AND STEREOTACTIC BRAIN SURGERY DEVICENovember 2021February 2024Allow2720NoNo
17450788METHOD FOR OPERATING A FEEDING SET AND ENTERAL FEEDING PUMPOctober 2021March 2025Allow4110YesNo
17484438INDWELLING NEEDLE FOR SUBCUTANEOUS ADMINISTRATIONSeptember 2021April 2024Abandon3120NoNo
17472886SYSTEM AND METHOD FOR SAFETY SYRINGESeptember 2021July 2023Allow2210YesNo
17467691CELL TRANSPLANTATION DEVICE AND CELL TRANSPLANTATION SYSTEMSeptember 2021April 2025Abandon4310NoNo
17462211METHODS OF IMPLANTING BARBED MICROCATHETERS HAVING FLUID EGRESS OPENINGS FOR INFUSING THERAPEUTIC FLUIDS INTO TISSUEAugust 2021June 2025Abandon4520NoNo
17408670MANUFACTURE OF STEERABLE DELIVERY DEVICESAugust 2021April 2025Allow4410NoNo
17391865AUTOMATIC FEEDBACK MECHANISM AND A MEDICAMENT DELIVERY DEVICE WITH USER FEEDBACK CAPABILITYAugust 2021May 2023Allow2210NoNo
17352838CHEW TOY FOR DISPENSING MEDICATIONJune 2021December 2024Abandon4201NoNo
17413901PLASTIC PRIMARY PACK FOR INJECTION DEVICESJune 2021June 2025Abandon4820NoNo
17297726Securement Assembly for Enteral and Vesical Access Devices and Related MethodsMay 2021December 2024Allow4220YesNo
17330814ACTIVATION ASSEMBLY FOR A MEDICAMENT DELIVERY DEVICEMay 2021July 2023Allow2610YesNo
17296912EXTENDED DWELL AND MIDLINE CATHETERS AND RELATED METHODSMay 2021December 2024Allow4310NoNo
17292222Injector Pen AssemblyMay 2021February 2025Allow4630YesNo
17281339FLUID VESSEL INSERTION DEVICE WITH AUTOMATIC NEEDLE RETRACTIONMarch 2021December 2023Abandon3310NoNo
17213052INJECTION DEVICEMarch 2021March 2025Abandon4820NoNo
17278451INJECTION DEVICE WITH COMMIT FEATUREMarch 2021September 2024Abandon4110NoNo
17207234FLEXIBLE TIP CATHETERMarch 2021October 2023Allow3110YesNo
17185462Tube Crimping Arrangement for Drug Delivery DeviceFebruary 2021June 2023Allow2700NoNo
17157490DEVICE FOR DELIVERING MEDICATIONJanuary 2021November 2024Allow4620NoNo
17150655GUIDE WIRE HOLDERJanuary 2021September 2024Allow4420YesNo
17149277MICRONEEDLE SYSTEM AND METHOD OF FABRICATION OF AN INGESTIBLE STRUCTUREJanuary 2021November 2024Abandon4611YesNo
17247568STEERABLE ROTATIONAL HEMOSTASIS CLIPDecember 2020September 2024Allow4511NoNo
17252453Drug Delivery Device, Method for Manufacturing a Drug Delivery Device and Use of a Welded ConnectionDecember 2020March 2024Allow3910YesNo
17114725CATHETER DESIGNS FOR ENHANCED COLUMN STRENGTHDecember 2020July 2023Allow3120YesNo
17056703DEVICE AND METHOD FOR DISPENSING AT LEAST ONE SUBSTANCENovember 2020May 2024Allow4110NoNo
16950510Syringe Carrier for an Autoinjector and Method of AssemblingNovember 2020February 2025Allow5120NoNo
17047241CATHETER ASSEMBLIES AND RELATED METHODSOctober 2020October 2023Abandon3620NoNo
17044490DIVERTING JEJUNOSTOMY TUBEOctober 2020February 2023Allow2820YesNo
17041452TWO-COMPONENT-MIXING PREFILLED SYRINGE KITSeptember 2020November 2024Abandon5021NoNo
16968350MEDICAMENT DELIVERY DEVICE WITH EASILY CONNECTED DISPOSABLE AND REUSABLE UNITSAugust 2020September 2024Allow5030NoNo
16966562DRUG INJECTION DEVICE WITH DEFLECTABLE TRANSDUCERJuly 2020December 2023Allow4110YesNo
16964281TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH A PDE4 INHIBITORJuly 2020April 2025Allow5730NoNo
16964306A VALVE FOR AN INJECTION DEVICE AND AN INJECTION DEVICE WITH SUCH A VALVEJuly 2020March 2024Abandon4410NoNo
16922649CATHETER INCLUDING SURFACE-TREATED STRUCTURAL SUPPORT MEMBERJuly 2020August 2024Allow4961YesYes
16922137Self-Controllable Load Spring WasherJuly 2020December 2024Allow5431YesNo
16918216PUNCTURE NEEDLEJuly 2020September 2022Allow2740YesNo
16954029INTRA-CAVITY CIRCULATION HEAT PERFUSION APPARATUSJune 2020May 2023Allow3520YesNo
16887161EXTENSION TUBE ASSEMBLY AND RELATED MEDICAL FLUID TRANSFER SYSTEMS AND METHODSMay 2020February 2023Allow3320YesNo
16768288Injection DeviceMay 2020May 2023Allow3520YesNo
16768349Injector DeviceMay 2020December 2023Allow4350YesNo
16764620MEDICAL DEVICEMay 2020September 2023Allow4010YesNo
16875793SPLIT OVERTUBE ASSEMBLYMay 2020March 2023Allow3420YesNo
16760592NEEDLE SHROUD ASSEMBLY AND DRUG DELIVERY DEVICEApril 2020May 2023Allow3740YesNo
16759675Injector DeviceApril 2020November 2023Allow4230YesNo
16846446GUIDE WIREApril 2020August 2022Allow2810YesNo
16845065Autoinjector and Method of Injecting FluidsApril 2020June 2023Allow3911YesNo
16651448Safety Needle and Safety Needle DeviceMarch 2020September 2022Allow3010NoNo
16651404FIXATION OF MEDICAL TUBING WITH FLUIDUM FILLED CHAMBERMarch 2020August 2022Allow2940YesNo
16827612INTRODUCER SHEATH FOR PROSTHETIC HEART VALVEMarch 2020June 2023Abandon3920NoNo
16649861BIOACTIVE AGENT DISTRIBUTIONMarch 2020December 2024Allow5740YesYes
16649029INVASIVE MEDICAL DEVICE AND MANUFACTURING METHODSMarch 2020February 2023Allow3511NoNo
16798369Pressure-Stabilized Ear Flushing Device Capable of Being Operated with One HandFebruary 2020May 2023Abandon3920NoNo
16789966SHAFT FOR A CATHETER AND FABRICATION METHODFebruary 2020August 2023Allow4251YesNo
16637624EXPANDABLE AND AUTOMATICALLY RETRACTABLE COLLAR AND METHOD OF USE THEREOFFebruary 2020February 2023Allow3620NoNo
16635935SELF-DEPLOYING INJECTOR FOR IMPLANTS AND METHODS OF MAKING AND USING SAMEJanuary 2020September 2022Abandon3110NoNo
16773167SYRINGE FOR ADMINISTERING A PHARMACEUTICAL SUBSTANCEJanuary 2020August 2022Abandon3110NoNo
16747194SYSTEMS AND METHODS FOR INSTILLATION PURGINGJanuary 2020May 2023Allow4031NoNo
16632521Assisted Injection Device for Injecting a Composition Contained in a Medical ContainerJanuary 2020October 2022Allow3320YesNo
16631732Catheter for Atraumatic Fluid DeliveryJanuary 2020May 2023Abandon4030NoNo
16631510CHEMICALLY DRIVEN AUTO-INJECTOR WITH RETRACTIONJanuary 2020April 2022Allow2710YesNo
16742456PATENCY CHECKING SYSTEMJanuary 2020October 2021Allow2110YesNo
16630569INFUSION PRESSURE CONTROL SYSTEMJanuary 2020March 2023Allow3840YesNo
16630379ADMINISTRATION ASSEMBLY FOR A MEDICAMENT DELIVERY DEVICE AND A MEDICAMENT DELIVERY DEVICE COMPRISING THE SAMEJanuary 2020February 2022Allow2510YesNo
16623828SYSTEM AND METHOD FOR DRIVE MEMBER POSITION AND FLUID INJECTOR SYSTEM MECHANICAL CALIBRATIONDecember 2019June 2023Allow4211YesNo
16623277PEN NEEDLE MULTIPLE CARRIER INJECTION SYSTEMDecember 2019September 2022Allow3320YesNo
16710702INTRODUCER ASSEMBLY PARTICULARLY FOR BALLOON CATHETERSDecember 2019October 2022Allow3411YesNo
16708065AUTO-RETRACTABLE SAFETY BLOOD COLLECTION NEEDLEDecember 2019August 2021Allow2001YesNo
16616018STERILE PUMP MODULE FOR AN INFUSION PUMPNovember 2019May 2022Allow3020YesNo
16687024FLUID PATH CHANNEL AND ADSORBENTNovember 2019January 2023Allow3830YesNo
16671044GUIDEWIRE HAVING PARABOLIC GRIND PROFILEOctober 2019October 2022Abandon3530NoNo
16607903INJECTION DEVICE WITH PRIMING ARRANGEMENTOctober 2019March 2022Abandon2910NoNo
16601599SYRINGE DEVICEOctober 2019January 2022Abandon2710NoNo
16599729EVENT DETECTION FOR DRUG DELIVERY SYSTEMOctober 2019September 2022Allow3620YesNo
16604275AUTOMATIC FLUID PRODUCT INJECTION DEVICEOctober 2019September 2021Allow2310YesNo
16586810LIQUID MEDICINE ADMINISTRATION DEVICE AND GASKET BIASING MEMBER ASSEMBLYSeptember 2019September 2022Allow3610YesNo
16580129INJECTION DEVICESeptember 2019August 2022Allow3420NoNo
16494513INJECTION DEVICE WITH DELIVER PHASE VELOCITY REGULATORSeptember 2019January 2022Allow2810YesNo
16494339LOW FORCE TRIGGERSeptember 2019December 2021Allow2710YesNo
16492881STEERABLE CATHETERSeptember 2019August 2021Allow2410NoNo
16552975BUBBLE DETECTOR AND RELATED BUBBLE DETECTION METHODOLOGY FOR A MEDICATION FLUID INFUSION SYSTEMAugust 2019May 2022Abandon3320YesNo
16552066CATHETER ASSEMBLYAugust 2019January 2022Allow2821YesNo
16534819CATHETER BODY AND HUB SECURING APPARATUSAugust 2019November 2021Allow2820YesNo
16483661Medicament Delivery DevicesAugust 2019September 2021Allow2610YesNo
16532132LOW-DRAG SEPTUM FOR A CATHETER SYSTEMAugust 2019May 2022Allow3321YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner GOLLAMUDI, NEERAJA.

Strategic Value of Filing an Appeal

Total Appeal Filings
3
Allowed After Appeal Filing
2
(66.7%)
Not Allowed After Appeal Filing
1
(33.3%)
Filing Benefit Percentile
92.4%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 66.7% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner GOLLAMUDI, NEERAJA - Prosecution Strategy Guide

Executive Summary

Examiner GOLLAMUDI, NEERAJA works in Art Unit 3783 and has examined 140 patent applications in our dataset. With an allowance rate of 77.1%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 35 months.

Allowance Patterns

Examiner GOLLAMUDI, NEERAJA's allowance rate of 77.1% places them in the 36% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by GOLLAMUDI, NEERAJA receive 2.01 office actions before reaching final disposition. This places the examiner in the 66% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by GOLLAMUDI, NEERAJA is 35 months. This places the examiner in the 21% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +40.0% benefit to allowance rate for applications examined by GOLLAMUDI, NEERAJA. This interview benefit is in the 89% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 28.0% of applications are subsequently allowed. This success rate is in the 40% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 48.1% of cases where such amendments are filed. This entry rate is in the 67% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 66.7% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 55% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 99% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 0.0% are granted (fully or in part). This grant rate is in the 5% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 43% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 42% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.